Drug interaction classified as: metabolism
Source: DDInter
Antifungal
Miconazole is an imidazole antifungal that inhibits fungal lanosterol 14-α-demethylase (CYP51), depleting ergosterol from cell membranes and causing accumulation of toxic methylated sterol intermediates. At higher concentrations, it also directly damages fungal cell membranes by interacting with membrane phospholipids. Unlike the systemically used triazoles, miconazole is primarily used topically due to its less selective inhibition of mammalian cytochrome P450 enzymes; however, even topical oral gel formulations can inhibit CYP2C9 sufficiently to potentiate warfarin.
X
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Drug interaction classified as: metabolism
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Profound hypoglycemia, potentially life-threatening.
Avoid concomitant use. If miconazole is essential, consider alternative antidiabetic agents or switch to insulin and monitor blood glucose very closely.
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e, Harrison 22e, BNF·Verified: 2026-05-13 · House clinical team